Publix Pharmaceuticals Nigeria Limited has joined the fight against malaria by introducing into the Nigeria market a top of the range, high quality World Health Organisation (WHO)-recommended ACT formulation 80/480 Publitem tablets and suspension.
The new product contains Artemether and Lumefantrin
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
TIAMIYU ADIO
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
